Slide 1: Q2/H1 2018 Report Conference Call
aap Implantate AG Q2/H1 2018 Report Conference Call Bruke Seyoum Alemu, CEO Marek Hahn, CFO Berlin, August 14, 2018
Slide 2: Safe Harbor Statement
Safe Harbor Statement Our publication may include predictions, estimates or other information that might be considered forward-looking. While these forward-looking statements represent our current judgment on what the future holds, they are subject to risks and uncertainties that could cause actual
Slide 3: Key results and progress Q2/2018 and H1/2018
Key results and progress Q2/2018 and H1/2018 ➢ Sales and Earnings ▪ Q2 sales (EUR 2.7 million) and EBITDA (EUR -1.5 million) at upper end of the guidance ▪ Q2 sales +13% yoy, Q2 trauma sales +16% yoy, H1 trauma sales +5% yoy ▪ Double digit sales growth rates in focus market Germany (+28% yoy in Q2,
Slide 4: Financial Figures Q2/2018
Financial Figures Q2/2018 (in KEUR) Sales (reported) Q2/2018 Q2/2017 Change Trauma 2,678 2,310 +16% Germany 735 576 +28% North America 621 675 -8% North America Distributors 584 675 -13% North America Global Partners 37 0 >+100% International 1,322 1,059 +25% Other (mainly discontinued activities in
Slide 5: Financial Figures H1/2018
Financial Figures H1/2018 (in KEUR) Sales (reported) H1/2018 H1/2017 Change Trauma 5,475 5,210 +5% Germany 1,391 1,210 +15% North America 1,151 1,718 -33% North America Distributors 1,097 1,253 -13% North America Global Partners 55 465 -88% International 2,932 2,282 +28% Other (mainly discontinued a
Slide 6: Financial Figures Q2/2018 (EBITDA)
Financial Figures Q2/2018 (in KEUR) EBITDA Q2/2018 Q2/2017 Change EBITDA -1,530 -1,642 +7% 6
Slide 7: Financial Figures H1/2018 (EBITDA)
Financial Figures H1/2018 (in KEUR) EBITDA H1/2018 H1/2017 Change EBITDA -3,118 -3,307 +6% 7
Slide 8: Highlights H1/2018 (Balance Sheet)
Highlights H1/2018 (Balance Sheet) ➢ Total assets 06/30/2018: EUR 46.3 million (12/31/2017: EUR 50.5 million) -9% ▪ Non-current assets: almost unchanged, but countervailing effects Capitalized development costs: EUR +0.6 million Share of intangible assets in total assets: 27% healthy ratio
Slide 9: Highlights H1/2018 (Cash Flow)
Highlights H1/2018 (Cash Flow) ➢ Operating Cash Flow H1/2018: EUR -2.3 million (H1/2017: EUR -2.9 million) ▪ Improved operating result (EBIT) ▪ Positive contribution from working capital of EUR 0.8 million, stable DSO of 84 days in H1/2018 (FY/2017: 85 days) ▪ Utilization of provisions taken in FY/2
Slide 10: Outlook
Outlook Q3/2018 – Sales: EUR 2.0 million – EUR 3.8 million (Q3/2017: EUR 2.6 million) – EBITDA: EUR -1.8 million – EUR -0.9 million (Q3/2017: EUR -1.6 million) FY/2018 – Overall, aap confirms its outlook for financial year 2018 and expects sales and EBITDA at the lower end of the guidance of EUR 13
Slide 11: Many thanks for your attention!
Many thanks for your attention! Lorenzweg 5 • 12099 Berlin • Germany Fabian Franke Manager Investor Relations Tel.: +49 30 750 19 – 134 Fax: +49 30 750 19 – 290 E-Mail: ir@aap.de IR-app: 11